[Diagnosis, treatment and prevention of infections caused by fungi in HIV-positive patients].
Fortun Abete
J
J
Unidad de Enfermedades Infecciosas, Hospital Ramón y Cajal, Madrid.
D017088:AIDS-Related Opportunistic Infections / Q000175:diagnosis / Q000188:drug therapy / Q000517:prevention & control; D000328:Adult; D000666:Amphotericin B / Q000008:administration & dosage / Q000627:therapeutic use; D000935:Antifungal Agents / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D001228:Aspergillosis / Q000175:diagnosis / Q000188:drug therapy; D002177:Candidiasis / Q000175:diagnosis / Q000188:drug therapy; D002180:Candidiasis, Oral / Q000175:diagnosis / Q000188:drug therapy; D002181:Candidiasis, Vulvovaginal / Q000175:diagnosis / Q000188:drug therapy; D002648:Child; D002986:Clinical Trials as Topic; D003453:Cryptococcosis / Q000175:diagnosis / Q000188:drug therapy; D004352:Drug Resistance, Microbial; D004935:Esophageal Diseases / Q000175:diagnosis / Q000188:drug therapy; D005260:Female; D015725:Fluconazole / Q000008:administration & dosage / Q000627:therapeutic use; D005658:Fungi / Q000187:drug effects; D006801:Humans; D007654:Ketoconazole / Q000008:administration & dosage / Q000627:therapeutic use; D008297:Male; D012189:Retrospective Studies
D000935:Antifungal Agents; D000666:Amphotericin B; D015725:Fluconazole; D007654:Ketoconazole